ArticleArchives of medical science : AMS2022

Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting.

Dorota Zarębska-Michaluk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.